Invesco
BRLI

Invesco’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Invesco’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-115,292
Closed -$4.75M – 4251
2015
Q2 		$4.75M Sell
115,292
-3,602
-3% -$129K ﹤0.01% 2029
2015
Q1 		$4.19M Sell
118,894
-2,433
-2% -$82.3K ﹤0.01% 2100
2014
Q4 		$3.9M Buy
121,327
+8,808
+8% +$255K ﹤0.01% 2069
2014
Q3 		$3.16M Buy
112,519
+9,315
+9% +$284K ﹤0.01% 2246
2014
Q2 		$3.12M Buy
103,204
+814
+0.8% +$22.5K ﹤0.01% 2303
2014
Q1 		$2.83M Buy
102,390
+24,551
+32% +$642K ﹤0.01% 2330
2013
Q4 		$1.99M Buy
77,839
+709
+0.9% +$21.9K ﹤0.01% 2668
2013
Q3 		$2.31M Buy
77,130
+12,031
+18% +$335K ﹤0.01% 2440
2013
Q2 		$1.87M Buy
+65,099
New +$1.79M ﹤0.01% 2429

Other funds holding BRLI

SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Invesco's BRLI Position: Q3 2015 in Review

Invesco sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 115,292 shares — an estimated $4.75M sold.

Invesco first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $4.75M in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

  • Invesco reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
  • Invesco sold 115,292 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $4.75M.
  • Invesco first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
  • Invesco's BIO-REFERENCE LABS INC-NEW- position peaked at $4.75M in Q2 2015.
  • 1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Invesco's 13F filing for Q3 2015, filed 16 Nov 2015.